A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal

BACKGROUND: Levothyroxine (LT4) sodium is a standard treatment for hypothyroidism. Its absorption and bioavailability when taken as a tablet have been shown to be significantly decreased with concomitant food ingestion. Therefore, LT4 formulations are recommended to be taken on an empty stomach, at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ducharme, Murray, Scarsi, Claudia, Bettazzi, Elisa, Mautone, Giuseppe, Lewis, Yvette, Celi, Francesco S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419984/
https://www.ncbi.nlm.nih.gov/pubmed/35469428
http://dx.doi.org/10.1089/thy.2021.0604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419984/
https://www.ncbi.nlm.nih.gov/pubmed/35469428
http://dx.doi.org/10.1089/thy.2021.0604

Ejemplares similares